文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

澳大利亚年轻人对衣原体疫苗的接种意愿

Chlamydia vaccine willingness among young adults in Australia.
PubMed 文献 · Vaccine · 2025-11-27

该研究于2024年8月通过在线调查评估澳大利亚18-29岁性活跃年轻人对衣原体疫苗的接受度及相关因素,共纳入1002份问卷。结果显示84.1%愿意接种多性传播感染疫苗,79.7%愿意接种仅针对衣原体的疫苗;18-24岁及曾接种人乳头瘤病毒疫苗者接种意愿更高。

要点

  • 84.1%的受访者愿意接种多性传播感染疫苗,79.7%愿意接种仅针对衣原体的疫苗。
  • 18-24岁较25-29岁接种意愿更高(aOR=2.5;95%CI:1.4,4.2)。
  • 曾接种人乳头瘤病毒疫苗者接种意愿更高(aOR=2.9;95%CI:1.7,5.0)。

核心结论

  • 澳大利亚年轻人对性传播感染认知度高但存在特定知识缺口,风险感知相对较低,提示需要更好的公共卫生沟通和知识提升活动。
  • 对多性传播感染尤其是衣原体疫苗的强烈接种意愿表明未来疫苗开发和研究的潜力。

研究设计与样本

  • 2024年8月通过在线调查,使用Life in Australia概率面板和i-Link非概率面板招募18-29岁性活跃澳大利亚年轻人,两个样本数据经统计混合和加权以代表该人群,共完成并分析1002份问卷。

主要发现

  • 尽管对性传播感染认知度高(93.3%),尤其对衣原体(88.4%),但存在传播相关误解。
  • 46.1%曾接受性传播感染检测,27.9%认为自己有风险;检测者中衣原体(14.7%)是最常报告的感染。
  • 自认有风险者中最担心人类免疫缺陷病毒(43.0%),其次为生殖器疱疹(15.8%)。
  • 84.1%表示愿意接种多性传播感染疫苗,79.7%愿意接种仅针对衣原体的疫苗。
  • 18-24岁较25-29岁接种意愿更高(aOR=2.5;95%CI:1.4,4.2),曾接种人乳头瘤病毒疫苗者较未接种者更高(aOR=2.9;95%CI:1.7,5.0)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Sexually transmitted infections (STIs) are among the most frequently reported diseases to Australia's National Notifiable Diseases Surveillance System, with chlamydia being notably prevalent among individuals aged 15-29 years. The study aims to assess the acceptability of chlamydia vaccine and the factors influencing it by investigating the awareness, knowledge and sexual behaviours of sexually active young adults in Australia. METHODS: In August 2024, an online survey was administered to sexually active young Australians aged 18-29 years using Life in Australia, a probability-based panel of the Social Research Centre, and the i-Link non-probability panel. Data from both samples were statistically blended and weighted to represent this population. A total of 1002 surveys were completed and included in the analysis. RESULTS: Despite high awareness of STIs (93.3 %), particularly regarding chlamydia (88.4 %), there were misconceptions about transmission. Overall, 46.1 % had undergone STI testing, and 27.9 % considered themselves at-risk. Among those tested, chlamydia (14.7 %) was the most frequently reported infection. Human immunodeficiency virus was the greatest concern among those perceiving themselves at risk (43.0 %), followed by genital herpes (15.8 %). Notably, 84.1 % expressed willingness to receive a multi-STI vaccine, and 79.7 % were willing to take a chlamydia-only vaccine. Odds of willingness to get vaccinated were higher for 18-24-year-olds compared with 25-29-year-olds (adjusted odds ratio [aOR] = 2.5; 95 % confidence interval [CI]: 1.4, 4.2) and higher for those who had been vaccinated against human papillomavirus (aOR = 2.9; 95 % CI: 1.7, 5.0). Prevention of new infections and reduction in transmission were the main reasons for vaccination interest. CONCLUSIONS: Young Australians were highly aware of STIs but demonstrated specific knowledge gaps. Despite moderate testing rates, the relatively low risk perception suggests the need for better public health communication and knowledge-raising campaigns. A strong willingness to get vaccinated against multiple STIs, particularly chlamydia, indicates potential for future vaccine development and research.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Chaves SS, Castells VB, Wagué S, et al. Chlamydia vaccine willingness among young adults in Australia. Vaccine. 2025. PMID: 41313896. doi:10.1016/j.vaccine.2025.128027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。